Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia

BackgroundCommunity-acquired pneumonia (CAP) is an extraordinarily heterogeneous illness, both in the range of responsible pathogens and the host response. Metagenomic next-generation sequencing (mNGS) is a promising technology for pathogen detection. However, the clinical application of mNGS for pa...

Full description

Bibliographic Details
Main Authors: Tianlai Lin, Xueliang Tu, Jiangman Zhao, Ling Huang, Xiaodong Dai, Xiaoling Chen, Yue Xu, Wushuang Li, Yaoyao Wang, Jingwei Lou, Shouxin Wu, Hongling Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1136588/full
_version_ 1797743152257302528
author Tianlai Lin
Xueliang Tu
Jiangman Zhao
Jiangman Zhao
Ling Huang
Xiaodong Dai
Xiaoling Chen
Yue Xu
Yue Xu
Wushuang Li
Wushuang Li
Yaoyao Wang
Yaoyao Wang
Jingwei Lou
Jingwei Lou
Shouxin Wu
Hongling Zhang
author_facet Tianlai Lin
Xueliang Tu
Jiangman Zhao
Jiangman Zhao
Ling Huang
Xiaodong Dai
Xiaoling Chen
Yue Xu
Yue Xu
Wushuang Li
Wushuang Li
Yaoyao Wang
Yaoyao Wang
Jingwei Lou
Jingwei Lou
Shouxin Wu
Hongling Zhang
author_sort Tianlai Lin
collection DOAJ
description BackgroundCommunity-acquired pneumonia (CAP) is an extraordinarily heterogeneous illness, both in the range of responsible pathogens and the host response. Metagenomic next-generation sequencing (mNGS) is a promising technology for pathogen detection. However, the clinical application of mNGS for pathogen detection remains challenging.MethodsA total of 205 patients with CAP admitted to the intensive care unit were recruited, and broncho alveolar lavage fluids (BALFs) from 83 patients, sputum samples from 33 cases, and blood from 89 cases were collected for pathogen detection by mNGS. At the same time, multiple samples of each patient were tested by culture. The diagnostic performance was compared between mNGS and culture for pathogen detection.ResultsThe positive rate of pathogen detection by mNGS in BALF and sputum samples was 89.2% and 97.0%, which was significantly higher (P < 0.001) than that (67.4%) of blood samples. The positive rate of mNGS was significantly higher than that of culture (81.0% vs. 56.1%, P = 1.052e-07). A group of pathogens including Mycobacterium abscessus, Chlamydia psittaci, Pneumocystis jirovecii, Orientia tsutsugamushi, and all viruses were only detected by mNGS. Based on mNGS results, Escherichia coli was the most common pathogen (15/61, 24.59%) of non-severe patients with CAP, and Mycobacterium tuberculosis was the most common pathogen (21/144, 14.58%) leading to severe pneumonia. Pneumocystis jirovecii was the most common pathogen (26.09%) in severe CAP patients with an immunocompromised status, which was all detected by mNGS only.ConclusionmNGS has higher overall sensitivity for pathogen detection than culture, BALF, and sputum mNGS are more sensitive than blood mNGS. mNGS is a necessary supplement of conventional microbiological tests for the pathogen detection of pulmonary infection.
first_indexed 2024-03-12T14:51:24Z
format Article
id doaj.art-1cfde1b8608c4255832da09c63bfd1a0
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-03-12T14:51:24Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-1cfde1b8608c4255832da09c63bfd1a02023-08-15T12:43:18ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882023-03-011310.3389/fcimb.2023.11365881136588Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumoniaTianlai Lin0Xueliang Tu1Jiangman Zhao2Jiangman Zhao3Ling Huang4Xiaodong Dai5Xiaoling Chen6Yue Xu7Yue Xu8Wushuang Li9Wushuang Li10Yaoyao Wang11Yaoyao Wang12Jingwei Lou13Jingwei Lou14Shouxin Wu15Hongling Zhang16Department of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, ChinaDepartment of Clinical Laboratory, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, ChinaShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, ChinaShanghai Zhangjiang Institute of Medical Innovation, Shanghai, ChinaDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, ChinaDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, ChinaDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, ChinaShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, ChinaShanghai Zhangjiang Institute of Medical Innovation, Shanghai, ChinaShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, ChinaShanghai Zhangjiang Institute of Medical Innovation, Shanghai, ChinaShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, ChinaShanghai Zhangjiang Institute of Medical Innovation, Shanghai, ChinaShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, ChinaShanghai Zhangjiang Institute of Medical Innovation, Shanghai, ChinaShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, ChinaDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, ChinaBackgroundCommunity-acquired pneumonia (CAP) is an extraordinarily heterogeneous illness, both in the range of responsible pathogens and the host response. Metagenomic next-generation sequencing (mNGS) is a promising technology for pathogen detection. However, the clinical application of mNGS for pathogen detection remains challenging.MethodsA total of 205 patients with CAP admitted to the intensive care unit were recruited, and broncho alveolar lavage fluids (BALFs) from 83 patients, sputum samples from 33 cases, and blood from 89 cases were collected for pathogen detection by mNGS. At the same time, multiple samples of each patient were tested by culture. The diagnostic performance was compared between mNGS and culture for pathogen detection.ResultsThe positive rate of pathogen detection by mNGS in BALF and sputum samples was 89.2% and 97.0%, which was significantly higher (P < 0.001) than that (67.4%) of blood samples. The positive rate of mNGS was significantly higher than that of culture (81.0% vs. 56.1%, P = 1.052e-07). A group of pathogens including Mycobacterium abscessus, Chlamydia psittaci, Pneumocystis jirovecii, Orientia tsutsugamushi, and all viruses were only detected by mNGS. Based on mNGS results, Escherichia coli was the most common pathogen (15/61, 24.59%) of non-severe patients with CAP, and Mycobacterium tuberculosis was the most common pathogen (21/144, 14.58%) leading to severe pneumonia. Pneumocystis jirovecii was the most common pathogen (26.09%) in severe CAP patients with an immunocompromised status, which was all detected by mNGS only.ConclusionmNGS has higher overall sensitivity for pathogen detection than culture, BALF, and sputum mNGS are more sensitive than blood mNGS. mNGS is a necessary supplement of conventional microbiological tests for the pathogen detection of pulmonary infection.https://www.frontiersin.org/articles/10.3389/fcimb.2023.1136588/fullmetagenomic next-generation sequencingculturecommunity-acquired pneumoniaconventional microbiological testpathogen detection
spellingShingle Tianlai Lin
Xueliang Tu
Jiangman Zhao
Jiangman Zhao
Ling Huang
Xiaodong Dai
Xiaoling Chen
Yue Xu
Yue Xu
Wushuang Li
Wushuang Li
Yaoyao Wang
Yaoyao Wang
Jingwei Lou
Jingwei Lou
Shouxin Wu
Hongling Zhang
Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
Frontiers in Cellular and Infection Microbiology
metagenomic next-generation sequencing
culture
community-acquired pneumonia
conventional microbiological test
pathogen detection
title Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
title_full Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
title_fullStr Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
title_full_unstemmed Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
title_short Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
title_sort microbiological diagnostic performance of metagenomic next generation sequencing compared with conventional culture for patients with community acquired pneumonia
topic metagenomic next-generation sequencing
culture
community-acquired pneumonia
conventional microbiological test
pathogen detection
url https://www.frontiersin.org/articles/10.3389/fcimb.2023.1136588/full
work_keys_str_mv AT tianlailin microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT xueliangtu microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT jiangmanzhao microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT jiangmanzhao microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT linghuang microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT xiaodongdai microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT xiaolingchen microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT yuexu microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT yuexu microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT wushuangli microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT wushuangli microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT yaoyaowang microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT yaoyaowang microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT jingweilou microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT jingweilou microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT shouxinwu microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia
AT honglingzhang microbiologicaldiagnosticperformanceofmetagenomicnextgenerationsequencingcomparedwithconventionalcultureforpatientswithcommunityacquiredpneumonia